DNA methyltransferases as DNMT3A mediate de novo DNA methylation and DNMT3A mutations were found to be prevalent across myeloid malignancies, primarily in AML and MPN [53]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.